optical mapping
Bionano Genomics Shifts Focus to Existing Users, Plans Further Layoffs as Q3 Revenues Fall Short
Premium
Strapped for cash, the optical genome mapping company's Q3 revenues declined 34 percent year over year, falling below the Wall Street consensus estimate.
Bionano Genomics to Raise $3M in Direct Stock Offering
The company also adjourned a special stockholder meeting to Nov. 27 to vote on the issuance of unregistered clinical milestone-linked warrants it placed in July.
Bionano Genomics Preliminary Q3 Revenues Below Guidance
For Q3, the firm anticipates revenues to be between $6.5 million and $6.8 million, down from the previous guidance of $7.9 million to $8.9 million.
Bionano Genomics Lays off Nearly Half of Workforce, Lowers Full-Year 2024 Guidance
After the fourth round of layoffs, the optical genome mapping company will focus on its existing customers while placing less emphasis on new instrument sales.
Bionano Genomics Lowers Full-Year Guidance Due to Weak Sales in China
The optical genome mapping company's business also took a hit from its massive layoffs, which were part of ongoing cost-reduction measures.